Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

I asked him whether he had any further generics in mind to pursue, and he said no, because he wanted to concentrate on gaining approval for new drugs, and on building FOB partnerships.

I could have told you that—see #msg-64171931 :- )